Countdown to 2021 CBIIC：
Chief Researcher of MENET
Graduated from the Department of Biopharmaceutics of China Medicine University, and entered the pharmaceutical information industry in the late 1990s. The first batch of entrants, practitioners, and researchers in the field of medical information in China are the promoters of the domestic medical information industry. Over the past 18 years, more than 500 mainstream Chinese pharmaceutical enterprises have conducted various types of market research projects. They have led the development of comprehensive market analysis, variety selection and product echelon formation, IPO fund investment to be researched, the terminal flow of large brands, and end of large brands that meet the needs of the domestic pharmaceutical market. Unique product types such as end check items, investment feasibility of pharmaceutical enterprises, etc. He is now a consultant for several pharmaceutical companies and fund securities companies. He has unique and in-depth insights in the pharmaceutical market analysis, forecasting, and analysis of major categories of pharmaceutical market, and has rich experience in marketing research and marketing planning and management.